Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
This makes Palynziq the only enzyme substitution therapy that received approval ...
AI is often described as a game changer in drug discovery and manufacturing. Wh...
The Jubilant Bhartia Foundation, the CSR arm of the Jubilant Bhartia Group in c...
Made in India, written by Sundeep Khanna and Manish Sabharwal, traces three rem...
India's Foremost Pharma & Biotech Magazine ~ When She Leads The post Express Ph...
The Bangalore District Chemists & Druggists Association (BDCDA) has submitted a...
Reportedly, 400+ delegates and 50 speakers were part of the summit The post IPA...
While we agree that “what got us here (an affordable generics powerhouse) will ...
Reportedly, 400+ delegates and 50 speakers were part of the summit The post IPA...
When patient safety is on the line, you need answers in minutes, not days. As s...
The acquisition will expand the company’s speciality pharmaceutical platform int...
FOP is an ultra-rare condition, impacting fewer than 1,000 people worldwide. The...
Inspection conducted in November 2025; Establishment Inspection Report issued b...
Transaction marks entry into global naturals market and sets up manufacturing a...
Company scores 91 out of 100; included in Sustainability Yearbook 2026 for thir...
Product bioequivalent to Hospira reference drug; IQVIA reports $66.8 million an...
